CALLIDITAS THERAPEUTICS AB's ticker is CALT and the CUSIP is 13124Q106. A total of 17 filers reported holding CALLIDITAS THERAPEUTICS AB in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $191,000 | -9.0% | 12,491 | +7.6% | 0.00% | – |
| Q2 2022 | $210,000 | -5.0% | 11,605 | +0.5% | 0.00% | – |
| Q1 2022 | $221,000 | +4.7% | 11,543 | +60.0% | 0.00% | – |
| Q2 2021 | $211,000 | -17.6% | 7,216 | -4.5% | 0.00% | – |
| Q4 2020 | $256,000 | +4.9% | 7,557 | -26.5% | 0.00% | – |
| Q3 2020 | $244,000 | +11.4% | 10,278 | +13.8% | 0.00% | – |
| Q2 2020 | $219,000 | – | 9,035 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 750,000 | $17,962,500 | 0.66% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 27,795 | $666,246 | 0.42% |
| DEUTSCHE BANK AG\ | 90,509 | $2,169,501 | 0.00% |
| Nalls Sherbakoff Group, LLC | 35 | $808 | 0.00% |
| Missouri Trust & Investment Co | 35 | $839 | 0.00% |
| Citadel Advisors | 20,500 | $490,975 | 0.00% |
| Citadel Advisors | 13,000 | $311,350 | 0.00% |
| MORGAN STANLEY | 1,387 | $33,246 | 0.00% |
| GROUP ONE TRADING, L.P. | 705 | $16,885 | 0.00% |
| Belpointe Asset Management LLC | 101 | $2,421 | 0.00% |